Inventor
Todd M. Kinsella
Inventor
Redwood City, CA, US
Overview
Patents· 44 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
C07KPeptides17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
C07DHeterocyclic compounds10%
C12NMicroorganisms or enzymes10%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
PatentTitleYear
11,111,305Method of using a bispecific antibody to conditionally inhibit a receptor signaling complex202111,104,737ACVR2A-specific antibody and method of treatment of muscle atrophy202111,021,468TGF-ss inhibitors202110,858,3352,3-Disubstituted pyridine compounds as TGF-b inhibitors and methods of use202010,822,337TGF-b inhibitorC202010,781,239In vivo engineered cereblon protein202010,759,855Antigen binding molecules to TIGIT202010,696,693Fused imidazole derivatives as TGF-beta inhibitors202010,287,295TGF-b inhibitors201910,233,1702,3-disubstituted pyridine compounds as TGF-beta inhibitors and methods of use20199,981,944GDF-8 inhibitors20189,970,925In vivo reporter system20189,884,868'TGF-beta inhibitors'20189,878,992'GDF-8 inhibitors'20189,845,512Screening assay employing Dex and GDF820179,644,224'Methods for cyclizing synthetic polymers'20179,518,040'GDF-8 inhibitors'20169,511,058'Methods for using carboxamide, sulfonamide and amine compounds'20169,145,433'GDF-8 inhibitors'20159,040,462'In vivo production of cyclic peptides for inhibiting protein-protein interaction'20158,796,254'Methods for using carboxamide, sulfonamide and amine compounds'20147,872,096'Methods for cyclizing synthetic polymers'20117,863,222'shRNA library'20117,604,951'Method for identifying compounds that modulate RXR associated processes with IgE production'20097,598,050'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein'20097,566,685'Methods and compositions for screening using diphtheria toxin constructs'20097,566,765'Heterocyclic compounds containing a nine-membered carbon-nitrogen ring'20097,563,585'Methods of assaying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein (TXNL)'20097,425,418'Compounds that modulate processes associated with IgE production'20087,422,867'Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein'20087,378,248'In vivo production of cyclic peptides for inhibiting protein-protein interaction'20087,378,251'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a thioredoxin-like 32 kDa protein'20087,374,894'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein'20087,252,952'In vivo production of cyclic peptides for inhibiting protein—protein interaction'20077,241,581'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a c-MYC protein'20077,208,289'Methods of identifying compounds that modulate IL-4 receptor mediated IgE synthesis utilizing a CLLD8 protein'20077,208,571'In vivo production of cyclic peptides'20077,189,523'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a B-cell associated protein'20077,141,434'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase'20067,105,341'In vivo production of cyclic peptides'20067,060,433'Methods and compositions for screening using diphtheria toxin constructs'20067,056,687'Methods and compositions for screening for altered cellular phenotypes'20066,979,549'Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein'20055,830,725'Rapid, stable high-titre production of recombing retrovirus'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–2006Based in Mountain View, CA, US· patent location history
2005–2021Patents assigned to RIGEL PHARMACEUTICALS INC (40)· patent assignee history
2005–2009Based in Fayetteville, NC, US· patent location history
2007–2021Based in Redwood City, CA, US· patent location history
2014–2015Patents assigned to KINSELLA TODD (2)· patent assignee history
2014–2015Patents assigned to PAYAN DONALD (2)· patent assignee history
2015–2018Patents assigned to KINSELLA TODD M (4)· patent assignee history
2018–2019Patents assigned to BRISTOL MYERS SQUIBB CO (3)· patent assignee history
2020Based in San Diego, CA, US· patent location history
2020Based in South San Francisco, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RIGEL PHARMACEUTICALS INC | 40 | 2005–2021 |
| KINSELLA TODD Mself | 4 | 2015–2018 |
| BRISTOL MYERS SQUIBB CO | 3 | 2018–2019 |
| KINSELLA TODDself | 2 | 2014–2015 |
| PAYAN DONALD | 2 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Redwood City, California, US | 27 | 2007–2021 |
| Fayetteville, NC, US | 12 | 2005–2009 |
| Mountain View, California, US | 3 | 1998–2006 |
| San Diego, California, US | 1 | 2020 |
| South San Francisco, California, US | 1 | 2020 |